Novartis signs up to $5.2 billion licensing deal with China’s biotech Argo for heart drugs
(Reuters) -Swiss drugmaker Novartis has signed an up to $5.2 billion licensing and options deal with Argo Biopharmaceutical…
Browsing Tag